GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CytoSorbents Corp (NAS:CTSO) » Definitions » Shiller PE Ratio

CytoSorbents (CytoSorbents) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2005. Start your Free Trial

What is CytoSorbents Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CytoSorbents Shiller PE Ratio Historical Data

The historical data trend for CytoSorbents's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoSorbents Shiller PE Ratio Chart

CytoSorbents Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CytoSorbents Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CytoSorbents's Shiller PE Ratio

For the Medical Devices subindustry, CytoSorbents's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytoSorbents's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CytoSorbents's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CytoSorbents's Shiller PE Ratio falls into.



CytoSorbents Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CytoSorbents's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, CytoSorbents's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.12/131.7762*131.7762
=-0.120

Current CPI (Mar. 2024) = 131.7762.

CytoSorbents Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.270 100.560 -0.354
201409 -0.220 100.428 -0.289
201412 -0.450 99.070 -0.599
201503 -0.190 99.621 -0.251
201506 0.050 100.684 0.065
201509 -0.110 100.392 -0.144
201512 -0.130 99.792 -0.172
201603 -0.070 100.470 -0.092
201606 -0.120 101.688 -0.156
201609 -0.090 101.861 -0.116
201612 -0.190 101.863 -0.246
201703 -0.060 102.862 -0.077
201706 -0.060 103.349 -0.077
201709 -0.070 104.136 -0.089
201712 -0.110 104.011 -0.139
201803 -0.100 105.290 -0.125
201806 -0.190 106.317 -0.235
201809 -0.100 106.507 -0.124
201812 -0.170 105.998 -0.211
201903 -0.150 107.251 -0.184
201906 -0.110 108.070 -0.134
201909 -0.210 108.329 -0.255
201912 -0.120 108.420 -0.146
202003 -0.100 108.902 -0.121
202006 -0.080 108.767 -0.097
202009 -0.020 109.815 -0.024
202012 -0.010 109.897 -0.012
202103 -0.100 111.754 -0.118
202106 -0.110 114.631 -0.126
202109 -0.150 115.734 -0.171
202112 -0.210 117.630 -0.235
202203 -0.210 121.301 -0.228
202206 -0.250 125.017 -0.264
202209 -0.280 125.227 -0.295
202212 -0.010 125.222 -0.011
202303 -0.170 127.348 -0.176
202306 -0.140 128.729 -0.143
202309 -0.210 129.860 -0.213
202312 -0.120 129.419 -0.122
202403 -0.120 131.776 -0.120

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CytoSorbents  (NAS:CTSO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CytoSorbents Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CytoSorbents's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CytoSorbents (CytoSorbents) Business Description

Traded in Other Exchanges
Address
305 College Road East, Princeton, NJ, USA, 08540
CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.
Executives
Edward Raymond Jones director 70 HOGAN LANE, AMBLER PA 19002
Kathleen P. Bloch officer: Chief Financial Officer 3 PERSHING COURT, NORTH BRUNSWICK NJ 08902
Vincent Capponi officer: Chief Operating Officer MEDASORB TECHNOLOGIES, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Phillip P. Chan director, officer: President and CEO 1001 BRIGGS ROAD, SUITE 280, MOUNT LAUREL NJ 08054
Efthymios Deliargyris officer: Chief Medical Officer C/O PLX PHARMA,INC.8285 EL RIO STREET, SUITE 210, HOUSTON TX 77054
Jiny Kim director C/O CYTOSORBENTS CORPORATION, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Alan D. Sobel director 293 EISENHOWER PARKWAY, LIVINGSTON NJ 07039
Michael G. Bator director C/O CYTOSORBENTS CORP., 7 DEER PARK DR., SUITE K, MONMOUTH JUNCTION NJ 08852
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Al Kraus director MEDASORB TECHNOLOGIES, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Eric R. Mortensen officer: Chief Medical Officer C/O CYTOSORBENTS CORPORATION, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Njtc Investment Fund, Lp 10 percent owner 1001 BRIGGS ROAD, SUITE 280, MOUNT LAUREL NJ 08054
Robert Shipley 10 percent owner 9 NOBLE ROAD, NOGALES AZ 85621
Ronald Berger officer: See Remarks 7 DEERPARK DRIVE, STE K, MONMOUTH JUNCTION NJ 08852
Thomas Bocchino officer: Chief Financial Officer C/O CYTOSORBENTS CORP., 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852